BTTX tear sheet

← Back to BTTXReportPortrait · background graphics on

SPZCOBetter Therapeutics — Nasdaq continued-listing non-compliance (min bid + MVLS); voluntary delist request 2024-03-14, 25-NSE 2024-05-16, deregistered 2024-05-30; wound down after debt default -> equity wiped · BTTXData at close 2024-03-14

· Prices AT CLOSE 2024-03-14 (USD)

Last $0.041Y +0.0%Off 52W high −90.0%Vol (1Y) 162.6%

Price2023-07-21 → 2026-07-21

BTTX close: $0.77 on 2023-07-21 to $0.00 on 2026-07-21.

Split-adj closes · 240 of 1,002 · price return

At a glance

Days to cover7.2d

SI 2026-07-31

Key fundamentals

BTTX joins the screener universe with the next build.

Trailing returns

YTD+0.0%

1Y+0.0%

3Y−100.0%

Since incept. (ann.)−92.2%

Total return · from 2021-11-01

Risk

Ann. volatility (1Y)162.6%

Ann. volatility (3Y)1440.4%

Sharpe (1Y)0.65

Sharpe (3Y)0.87

Max drawdown (1Y)−50.0%

Max drawdown (3Y)−100.0%

Beta (3Y vs SPY)−0.69

Daily returns, ann.

Top institutional holders13F 2026-Q1

Manager	Shares	Value	% sh out	QoQ
Ancora Advisors LLC	3,000	$0	—	+0.0%

Δ vs 2025-Q4 · % of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.

Latest reported quarters

No reported quarters on file for BTTX.

Basis & disclosures

EOD closes · nothing imputed or averaged · absent “—”
As-of differs by block · 13F = US long, 45+d lag, LOWER bound
Not investment advice · no recommendation, price target or solicitation
EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology